Greenwich LifeSciences (GLSI) - Shares outstanding

Number of shares outstanding as of December 2025 : 13,370,983

According to Greenwich LifeSciences's latest financial reports and stock price the company's current number of shares outstanding is 13,370,983. At the end of 2025 the company had 13,370,983 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Greenwich LifeSciences from 2019 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	13.37 M	1.74%
2024	13.14 M	2.29%
2023	12.84 M	0.19%
2022	12.82 M	-1.12%
2021	12.96 M	8.34%
2020	11.97 M	0%
2019	11.97 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Novocure NVCR	111,908,252	736.95%	Jersey
Novavax NVAX	162,353,000	1,114.22%	🇺🇸 USA
Organovo ONVO	1,504,713	-88.75%	🇺🇸 USA
Orchard Therapeutics ORTX	22,838,856	70.81%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Greenwich LifeSciences (GLSI)

Number of shares outstanding as of December 2025 : 13,370,983